ReviewVascular pharmacology2026

N6-methyladenosine (m6A) post-transcriptional modification regulation of mRNA, an overlooked therapeutic opportunity to leverage mRNA processing in vascular smooth muscle cells.

Dominick Openko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.